Description
This document is intended to provide guidance for “Animal Proteins Prohibited from use in Ruminant Feed,” 21 CFR 589.2000.
Scope & Applicability
Product Classes
1Regulation addresses the feeding of ruminant animals
Stakeholders
3verify that it is not being shipped to ruminant producers
Impacted by the regulation regarding ruminant animals
Feeders of ruminant animals without on-farm feed mixing operations
Regulatory Context
Attributes
3verify that feed not labeled with the cautionary statement is in fact being fed to nonruminant animals
maintenance of records means one year from the date of the receipt of the product
Limit for tallow to be considered nonprohibited
Related CFR Sections (2)
- 21CFR589.2000§ 589.2000 Animal proteins prohibited in ruminant feed.
(a) Definitions —Read full regulation →
- 21CFR589.2001§ 589.2001 Cattle materials prohibited in animal food or feed to prevent the transmission of bovine spongiform encephalopathy.
(a) Purpose. The purpose of this section is to prohibit the use of certain cattle origin materials in the food or feed of all animals to further reduce the risk of the spread of bovine spongiform encephalopathy (BSE) within the United States.Read full regulation →
See Also (8)
- Guidance for Industry: Sanitary Transportation of Food (Status: Final)
- CVM GFI #68 Small Entities Compliance Guide for Protein Blenders, Feed Manufacturers, and Distributors (Status: Final)
- CVM GFI #76 Questions and Answers BSE Feed Regulations (Status: Final)
- Content and Review of Chemistry, Manufacturing, and Control (CMC) Information for Human Somatic Cell Therapy Investigational New Drug Applications (INDs): Guidance for FDA Reviewers and Sponsors (Status: Final)
- CVM GFI #195 Small Entities Compliance Guide For Renderers—Substances Prohibited From Use In Animal Food Or Feed (Status: Final)
- CVM GFI #203 Ensuring Safety of Animal Feed Maintained and Fed On-Farm (Status: Final)
- CVM GFI #158 Use of Material from Deer and Elk in Animal Feed (Status: Final)
- Source Animal, Product, Preclinical, and Clinical Issues Concerning the Use of Xenotransplantation Products in Humans: Guidance for Industry (Status: Final)